Take a look at some of our highlights from the #LifeSciences sector in the first half of 2024, as well as market commentary from our M&A specialists across the globe – a huge thank you to our clients for entrusting us with their business objectives. Want to know more on the M&A market? Read our latest edition of Market Eye, where we examine a range individual sectors and offer insights into their performances and influencing factors: https://lnkd.in/dGbgQigY #MergersAndAcquisitions
Eversheds Sutherland Health and Life Sciences
Legal Services
Helping our clients, our people and our communities to thrive
About us
Our experienced life sciences lawyers can guide you through the entire life cycle of your idea, from intellectual property to worldwide marketing and compliance. Whether you are an inventor, start-up, venture capitalist, investor, Fortune 50 or Fortune 500 company, or research institution, we help people like you on all aspects of pharmaceuticals, biotechnology and medical devices. We understand that regulatory and compliance will dominate your thinking – and can help you meet your requirements on every issue from M&A to tax, HR and real estate.
- Website
-
https://www.eversheds-sutherland.com/global/en/what/industries/health-life-sciences/index.html
External link for Eversheds Sutherland Health and Life Sciences
- Industry
- Legal Services
- Company size
- 5,001-10,000 employees
- Specialties
- Health and Life Sciences, M&A, regulatory, Patent Litigation, Employment, Labor, Pensions, Real Estate, Data Privacy, Competition, Trade, Pricing, Commercial contracts, and Intellectual Property
Updates
-
We’re thrilled to announce that our legal team has been recognised as a Top Legal Adviser for UK Life Sciences M&A in 2024 by Merger Market this H1, building off our successes of 2023. But that’s not all, our recognition extends beyond borders as we also secure a spot as a Top 10 Legal Adviser for European Life Sciences M&A in 2024. As the first half of the year unfolds, we are excited for what lies ahead #lifesciences #MergerAndAcquisitions
-
Eversheds Sutherland Health and Life Sciences reposted this
*Health & Life Sciences (HALS) Sector Update - Labour Government’s life science-related policies* 💉 💊 🖥 The newly elected Labour Government’s life sciences strategy ('Prescription for Growth') was published back in February. Following the UK General Election, as a reminder, the core areas of focus are: 1) R&D investment: Labour promises to maintain R&D tax reliefs, while implementing a 10 year funding cycle for key R&D institutions. The newly elected government have also pledged to support the allocation of £520 million for life sciences manufacturing; 2) NHS: Labour have pledged to develop a NHS innovation and adoption strategy in England, including a clear procurement plan to give a clearer route for getting products into the NHS. They have also promised to deliver an extra 2 million NHS operations, scans and appointments every year, double the number of cancer scanners and recruit 8,500 additional mental health staff; and 3) Regulation/clinical trials: Labour have promised to establish a new Regulatory Innovation Office, increase clinical trial participation, improve researchers’ access to health data through the NHS app, and phase out animal testing. Wednesday, 17 July will be the date when we get a full picture of what the new Labour government’s priorities will be. King Charles will take part in the state opening of Parliament, which will see him read out the legislative agenda for the political year ahead. Contact my team Michael Johl, Olivia Hawkswell and Alexandra Liddell MA (Oxon) if you'd like to be put in touch with our dedicated Eversheds Sutherland HALS Sector specialists! Thanks to Lara Sabel for preparing this important summary.
-
Eversheds Sutherland Health and Life Sciences reposted this
📢 Updated guide! Routes to compliance: Global technology regulations and enforcement 💻✅ Technology regulations are evolving rapidly, and companies need to be aware of the different regulations that apply to them and take steps to comply. 👇🌎 Download our interactive guide, listing key laws, #regulations and developments across the US, UK, EU, the Middle East and APAC that are applicable to companies developing or deploying #technology including #AI. https://lnkd.in/dCEYRZZ6
-
The implications of the European Health Data Space (EHDS) are far-reaching. By enabling secure access to health data for research, innovation, and personalized treatments, it promises a healthier digital future for EU citizens. The industry must prepare to comply with the requirements of the EHDS in order to be granted access to health data for secondary use. Read our flash update below. #EHDS #EuropeanHealthDataSpace
-
Eversheds Sutherland Health and Life Sciences reposted this
Utilizing health data requires health and life sciences companies to tread a fine line between innovation and protecting patient privacy. In our latest #DataAsAnAsset podcast Philip James, Liz Fitzsimons, Leslie Bender and Magdalena Kotyrba-Hagenmaier highlight: · key US, EU and UK regulations global health and life sciences companies need to be aware of · the obstacles and opportunities for research, product development, patients and the public good · AI's potential for healthcare innovation Listen now: https://lnkd.in/epPi7gUP
-
-
Eversheds Sutherland Health and Life Sciences reposted this
The UK’s rapidly evolving AI patent landscape: The legal landscape in the UK regarding patent applications for #AI inventions is advancing swiftly. Indradeep Bhattacharya discusses the regulatory framework for patenting AI innovations in the UK as part of our Innovation Agenda series. Read now: https://lnkd.in/e_YXXSYJ
-
-
Eversheds Sutherland Health and Life Sciences reposted this
With increased digitalization, rapid advancements in technology and economic instability, it is no surprise that #TradeSecrets misappropriation and disputes are on the rise. In this Innovation Agenda update, we highlight recent cases impacting trade secret protection across the US, UK, EU and China to help you navigate this complex area of law. Read now: https://lnkd.in/eca4wWbT #IntellectualProperty
-
-
With the rapid advancement of Artificial Intelligence, the healthcare industry has and will be increasingly impacted – but how are the regulatory landscapes in the UK and EU shaping up to accommodate these innovations? Our latest article explores the evolving regulatory frameworks surrounding AI-powered medical devices. From diagnosing diseases to personalized treatments and real-time patient monitoring, AI is set to transform healthcare delivery. But with innovation comes challenges, particularly in classification, regulation, and ensuring patient safety. Read the full article here: https://lnkd.in/eQQ5gd25
-
-
Eversheds Sutherland Health and Life Sciences reposted this
📣 New guide: The #ArtificialIntelligence market is projected to reach $407bn by 2027 as it continues to revolutionize every industry and aspect of our lives. As more companies get on-board with new #AI systems, it is important to carefully consider the risks associated with their development and use. ‘All AI-Board’, our new legal guide to navigating AI, offers bite-sized, Board-level insights on the key legal issues raised around responsible AI and ethics, cybersecurity, data privacy, employment, IP, contracts and procurement and disputes. It also covers specific regulations to be aware of in the US, UK, Europe and China. Explore the interactive guide below to discover more. 👇 https://lnkd.in/ewUVhCjd #law